Tag: Lassa Fever

  • Lassa fever kills 152 in Nigeria – NCDC

    Lassa fever kills 152 in Nigeria – NCDC

    The Nigeria Centre for Disease Control and Prevention (NCDC) has reported a total of 152 deaths from Lassa fever in the first 28 weeks of 2025.

    This marks a higher case fatality rate (CFR) of 18.7 per cent compared to 17.3 per cent within the same period in 2024.

    According to the latest situation report released by the NCDC on Monday via its official website, 811 confirmed cases and over 6,520 suspected infections have been recorded so far.

    The Public Health agency said that these span 21 states and 105 local government areas, with the highest burden concentrated in Ondo, Bauchi, Edo, Taraba and Ebonyi states

    “We are witnessing a slight decline in the total number of confirmed cases compared to 2024, but the fatality rate has increased,” it said.

    It also indicated possible late presentation, poor health-seeking behaviour and limited access to early treatment as contributing factors.

    The agency said that in epidemiological week 28 alone, 11 new confirmed cases and one death were recorded, with reported infections from Ondo, Edo, and Benue states.

    It said that no healthcare workers were affected during the week.

    The NCDC said that individuals aged 21–30 years remained the most affected age group, with a nearly equal male-to-female distribution of cases

    In response to the ongoing outbreak, the agency and its partners have intensified interventions in high-burden areas.

    “Ten National Rapid Response Teams have been deployed to affected states using a One Health approach.

    “INTEGRATE Clinical Trials have commenced in Ondo state to support improved case management.

    “Healthcare workers in Bauchi, Ebonyi, and Benue states have received targeted training to strengthen clinical response,” it said.

    It said that environmental campaigns and community sensitisation activities were underway, in collaboration with Nigeria Health Watch, WHO, Pro-Health International, IHVN and other key partners.

    Meanwhile, the agency has launched its Infection Prevention and Control (IPC) e-learning platform, supported by the Global Fund.

    It distributed IPC materials and medical countermeasures such as Ribavirin, PPEs, and disinfectants to states and treatment centres.

    Despite intensified efforts, the NCDC said that several persistent challenges remained.

    “These include the late presentation of cases, which contributes to the high fatality rate.

    “Poor environmental sanitation in affected areas also hinders effective control of the disease.

    “Additionally, low awareness levels in vulnerable communities and the high cost of treatment continue to discourage prompt health-seeking behaviour.”

    The agency stressed the need for community engagement, early detection and prompt treatment to reduce fatalities as Nigeria battles to curb the spread of the disease.

    It appealed to the public to avoid contact with rodents and to seek prompt medical care at designated treatment centres at the first sign of symptoms such as fever, headache or bleeding.

    The NCDC urged Nigerians to continously maintain hygiene, report symptoms early and avoid contact with rodents and their secretions.

    “The public is also encouraged to follow NCDC advisories and utilise the toll-free line 6232 for inquiries,” it said.

    NAN reports that Lassa fever is a viral hemorrhagic disease transmitted primarily through contact with the urine or faeces of infected rats.

    It can also spread from person to person through bodily fluids, contaminated objects or infected medical equipment.

    Symptoms include fever, sore throat, headache, vomiting, muscle pain, and in severe cases, bleeding from the body openings.

  • Nigeria records 145 Lassa fever deaths, as fatality rate increases

    Nigeria records 145 Lassa fever deaths, as fatality rate increases

    Nigeria has recorded 145 deaths from Lassa fever as of 2025 Epidemiological Week 25, with a case fatality rate (CFR) of 18.6 per cent.

    The Nigeria Centre for Disease Control and Prevention (NCDC), disclosed this in its latest report via its official website on Saturday in Abuja.

    The NCDC said the week 25 figure marks an increase from 17.6 per cent reported for the same period in 2024.

    The report, which covered the week of June 16–22, revealed that 781 confirmed cases were reported out of 5,943 suspected cases across 20 states and 101 Local Government Areas (LGAs).

    In the current reporting week, 10 new confirmed cases were reported in Ondo and Edo states with a slight increase from the eight cases recorded the previous week.

    According to NCDC, 91 per cent of all confirmed cases in 2025 were reported from five states of Ondo (31%), Bauchi (24%), Edo (17%), Taraba (16%) and Ebonyi (3%).

    It said that the disease continues to affect young adults predominantly, within the 21 to 30 age group most impacted. Males were slightly more affected, with a male-to-female ratio of 1:0.8.

    The Nigerian public health agency, said that despite a decline in the overall number of suspected and confirmed cases compared to 2024, the rise in CFR is raising concerns among health experts.

    The agency highlighted late presentation of cases, high treatment costs, and poor health-seeking behaviour as contributing factors to the increased fatality.

    It said that no new infections among health workers were recorded in the reporting week, though 23 healthcare workers have been affected cumulatively this year.

    The NCDC said it is currently in collaboration with partners, such as the World Health Organisation (WHO), the United States Centers for Disease Control and Prevention (US CDC), ALIMA, the Institute of Human Virology Nigeria (IHVN) and others.

    The collaborations, it stated further have intensified multi-sectoral response efforts to combat the spread of Lassa fever.

    It said that, as part of these efforts, Integrate clinical trials are currently ongoing in Ondo State, with After Action Reviews (AARs) conducted in both Ondo and Ebonyi to evaluate the response to the outbreak.

    The agency said that clinician sensitisation, community engagement activities and environmental response campaigns have been carried out in identified hotspot areas.

    In addition, the NCDC said that it has deployed 10 national rapid response teams to various states, adopting a one health approach to disease control.

    To further strengthen infection prevention and control (IPC), the agency launched an IPC e-learning platform and distributed updated Viral Hemorrhagic Fever (VHF) guidelines to health facilities across the country.

    The agency said that other efforts also included active contact tracing, surveillance, media engagement and geospatial risk mapping, alongside regular webinars for clinicians and capacity-building sessions nationwide.

    The NCDC identified key challenges including poor environmental sanitation and low community awareness, particularly in high-burden LGAs.

    It also said that sustained efforts were needed to curb the fatality rate, ensure early detection, and improve public health outcomes.

    The NCDC advised Nigerians to maintain proper hygiene, avoid contact with rodents, and seek medical help promptly when experiencing symptoms such as fever, sore throat, vomiting, or unexplained bleeding.

    The News Agency of Nigeria (NAN), reports that Lassa fever, which was first identified in 1969 in Lassa, Borno, is endemic in Nigeria, with outbreaks occurring annually.

    Symptoms range from mild fever and joint pain to severe bleeding from the nose, mouth, and gastrointestinal tract.

    The disease is fatal in about 20 per cent of cases, particularly when treatment is delayed.

    Across West Africa, hundreds of thousands are infected annually, experiencing symptoms such as fever, vomiting and, in severe cases, bleeding.

    One of the most troubling complications is hearing loss, which affects about 25 per cent of survivors.

    The estimated fatality rate is one per cent, but during outbreaks, mortality can rise significantly, particularly among pregnant women and healthcare workers.

    In spite its significant health impact, Lassa fever remains one of the most neglected diseases, with limited resources allocated to its preventions and treatments.

    Currently, no licensed vaccines exist, although around 20 candidates are in development, with the most advanced in Phase IIa clinical trials.

  • NCDC confirms two new deaths, surge rises to 145

    NCDC confirms two new deaths, surge rises to 145

    The Nigeria Centre for Disease Control and Prevention (NCDC) has confirmed two new deaths from Lassa fever, bringing the total number of fatalities in 2025 to 145.

    TheNewsGuru reports that the country continues to grapple with the viral hemorrhagic disease, which is currently affecting 18 states.

    The latest update, contained in the NCDC’s situation report for Epidemiological Week 24 (June 9–15), revealed that 766 cases have been confirmed out of 5,678 suspected infections.

    The agency noted that the case fatality rate has risen to 18.9%, a concerning increase from 17.6% recorded during the same period in 2024.

    Five states—Ondo, Bauchi, Edo, Taraba, and Ebonyi—account for 91% of all confirmed cases. Ondo alone is responsible for 31%, cementing its status as the epicentre of the outbreak.

    Despite a slight drop in new confirmed cases (eight cases compared to 11 the previous week), the NCDC expressed deep concern over the persistently high fatality rate. It attributed this to delayed case reporting, poor health-seeking behaviour, and unhygienic living conditions in high-risk communities.

    A previous report released by the agency on Tuesday, June 17, confirmed that a health worker in Osun State had also been infected.

    In response, the NCDC has intensified its containment efforts, deploying Rapid Response Teams to 10 affected states. Other measures include public health education campaigns, environmental sanitation drives, and the training of healthcare workers in vulnerable regions.

    The agency has also scaled down its Incident Management System to alert mode and is integrating Lassa fever awareness into broader disease prevention campaigns.

    Lassa fever is a viral hemorrhagic illness primarily transmitted through contact with urine or faeces of infected rats. It can also spread between humans through bodily fluids, contaminated objects, or medical equipment. Symptoms include fever, sore throat, vomiting, headache, muscle pain, and in severe cases, internal bleeding.

    The NCDC continues to urge Nigerians to maintain good hygiene, avoid contact with rodents, and seek immediate medical attention at designated treatment centres when symptoms such as fever, bleeding, or headaches occur.

    “The public is also encouraged to follow NCDC advisories and call the toll-free line 6232 for inquiries or emergency support,” the agency stated.

  • Nigeria records 145 Lassa fever deaths

    Nigeria records 145 Lassa fever deaths

    The Nigeria Centre for Disease Control and Prevention (NCDC) has confirmed 145 deaths from Lassa fever in 2025, as the country continues to battle the viral hemorrhagic disease across 18 states.

    According to the latest situation report released on Friday by the NCDC for epidemiological week 24 (June 9–15), the country recorded 766 confirmed cases from 5,678 suspected infections.

    The case fatality rate stood at 18.9 per cent, up from 17.6 per cent during the same period in 2024.

    The agency said that the states most affected were Ondo, Bauchi, Edo, Taraba, and Ebonyi, which accounted for 91 per cent of the confirmed cases.

    It said that Ondo alone contributed 31 per cent making it the epicentre of the outbreak.

    In spite a decline in new confirmed cases — down to eight from 11 the previous week — the Nigerian public health agency said that health authorities remained concerned about the high fatality rate.

    The agency said that this was driven by late presentation of cases, poor health-seeking behaviour, and unsanitary living conditions in high-burden communities.

    According to it, efforts to contain the outbreak have included the deployment of Rapid Response Teams to 10 states, risk communication, environmental sanitation campaigns, and training of health workers in high-risk areas.

    The NCDC also de-escalated its Incident Management System to alert mode while integrating Lassa fever messages into wider disease awareness campaigns.

    The agency has appealed to the public to avoid contact with rodents and to seek prompt medical care at designated treatment centres at the first sign of symptoms such as fever, headache, or bleeding.

    The agency continues to urge Nigerians to maintain hygiene, report symptoms early, and avoid contact with rodents and their secretions.

    “The public is also encouraged to follow NCDC advisories and utilise the toll-free line 6232 for inquiries,” it said.

    Lassa fever is a viral hemorrhagic disease transmitted primarily through contact with the urine or faeces of infected rats.

    It can also spread from person to person through bodily fluids, contaminated objects, or infected medical equipment.

    Symptoms include fever, sore throat, headache, vomiting, muscle pain, and in severe cases, bleeding from the body openings.

  • Lassa fever death rate rises as cases spread – NCDC

    Lassa fever death rate rises as cases spread – NCDC

    The Nigeria Centre for Disease Control and Prevention (NCDC) has reported a rise in the fatality rate of Lassa fever, as the disease continues to spread across states with new confirmed cases and more deaths.

    The NCDC disclosed this in its latest situation report for Epidemiological Week 23, June 2–8, 2025, which was posted on its official website on Wednesday.

    According to the agency, Nigeria has recorded 143 deaths from 758 confirmed Lassa fever cases so far this year.

    This translates to a case fatality rate (CFR) of 18.9 per cent, higher than the 17.8 per cent recorded during the same period in 2024.

    The NCDC also revealed that 11 new confirmed cases were reported in the week under review, up from eight cases recorded the previous week. The new cases were detected in Ondo, Edo, Bauchi, and Taraba States.

    “In 2025, 18 states have recorded at least one confirmed case of Lassa fever, spread across 96 Local Government Areas.

    However, 90 per cent of all confirmed cases were reported from just five states: Ondo 31 per cent, Bauchi 25 per cent, Edo 16 per cent, Taraba 15 per cent, and Ebonyi 3 per cent,” the report stated.

    The agency noted that the age group most affected remained young adults aged 21 to 30 years, with a median age of 30.

    It also reported one new healthcare worker infection in the reporting week, bringing the total number of affected health workers in 2025 to 23.

    The NCDC identified several challenges fueling the outbreak, including late presentation of cases, poor health-seeking behaviour, and high cost of treatment, inadequate sanitation, and low awareness in affected communities.

    To curb the spread and reduce deaths, the agency said it had activated a multi-sectoral Incident Management System and deployed 10 Rapid Response Teams to states with the highest burden.

    Additional response measures included the training of health workers on case management, the launch of Infection Prevention and Control (IPC) e-learning platform, community sensitisation campaigns, environmental response interventions, and media outreach in collaboration with stakeholders.

    The NCDC urged Nigerians to maintain high hygiene standards, seek medical attention early when symptomatic, and avoid contact with rodents and their droppings, known vectors of the disease.

    Lassa fever is a viral hemorrhagic disease transmitted primarily through contact with the urine or faeces of infected rats.

  • FUTH to lead Nigeria’s lassa fever vaccine hub

    FUTH to lead Nigeria’s lassa fever vaccine hub

    The Federal University Teaching Hospital (FUTH), Lafia, is set to lead the establishment of Nigeria’s first vaccine research and development hub focused on Lassa fever and other infectious outbreaks.

    Dr Ikrama Hassan, FUTH’s Chief Medical Director (CMD), unveiled the initiative on Saturday in Abuja during the inaugural vaccine research retreat.

    Hassan said that the project was inspired by experience growing up in Lafia, the Nasarawa state capital, where yearly outbreak of a mysterious illness plagued communities, often misdiagnosed as typhoid fever.

    “It was not until my time at the University of Ibadan, studying Lassa fever, that I realised what had devastated my community for years was not typhoid.

    “Even as a trained physician, I did not know,” he said.

    He said that, as a former Director of Health Planning, Research, and Statistics in the state, he initiated the establishment of a vaccine research centre in 2019.

    “Despite the facility’s completion, it has remained dormant for over six years. Now, as CMD of the host institution, I have made activating the centre my top priority.

    “The impact will be monumental, not just for Nasarawa State, but for Nigeria and Africa as a whole,” he said.

    To advance the project, Hassan said that he had brought on board key stakeholders, including Dr Simon Agwale, vaccine development expert and CEO of Innovative Biotech, who also hails from Nasarawa.

    He said that Agwale had begun building partnerships with the Africa Centres for Disease Control (Africa CDC) and other global health agencies to support the centre.

    “If this group cannot make this centre a reality, I do not think there is another that can,” he said.

    He said that the COVID-19 pandemic had underscored the urgency of moving from reliance on imported vaccines to developing local solutions for epidemic-prone diseases like Lassa fever.

    “Lassa fever is endemic in several Nigerian states, including Nasarawa, with annual outbreaks and long-term complications such as hearing loss among survivors.

    “Despite its burden on public health, there is currently no widely available Lassa fever vaccine in the country,” he said.

    Speaking at the retreat, Agwale highlighted the power of vaccines in saving lives and preventing disease.

    He referenced the resurgence of measles in the U.S. as a cautionary tale of vaccine hesitancy.

    “Vaccines led to the eradication of smallpox. Today, we talk about eradicating polio only because of vaccines,” he said.

    “Vaccine development in Nigeria is hindered by limited early-stage research capacity and the absence of critical infrastructure.

    “There is no institution in Nigeria that we can rely on to generate early-stage data for vaccine development,” he said.

    He called for urgent investment in animal testing facilities, genomic labs, and other basic research infrastructure.

    “Science is not guesswork. Without animal testing infrastructure, it is just guesswork,” he said.

    Agwale said that Nigerian biotech companies were often forced to perform roles meant for universities due to capacity gaps in academic institutions.

    “As a biotech company, we are doing everything,” he said.

    He called for closer collaboration between academia, government, and industry, noting that locally developed vaccines can generate intellectual property (IP) to sustain universities financially.

    “If an academic institution develops the vaccine, the IP belongs to them. That’s how research becomes sustainable,” he said.

    He also drew attention to the global disparity in health research funding.

    “The U.S. National Institutes of Health has a budget over 40 billion dollars, more than Nigeria’s entire national budget,” he noted.

  • Lassa fever, meningitis kill 366 in 24 States – NCDC

    Lassa fever, meningitis kill 366 in 24 States – NCDC

    The Nigeria Centre for Disease Control and Prevention has reported a total of 366 deaths from Lassa fever and meningitis in 24 states of the federation.

    The NCDC via its official website on Friday, highlighted the continued public health challenge posed by these diseases.

    From Jan. 1 to May 18, the centre confirmed 733 cases of Lassa fever from 5,118 suspected infections across 18 states and 95 local government areas.

    Within the same period, it said it recorded 141 Lassa fever-related deaths, representing a case fatality rate of 19.2 per cent.

    The NCDC said that in week 20 alone, new infections jumped from three to 13 cases in Edo, Ondo, and Benue.

    “The case fatality rate stands at 19.2 per cent slightly higher than 18.3 per cent in 2024, indicating that one in five people infected is dying, inspite of  coordinated national efforts,” the NCDC warned.

    It said that the hotspot states for Lassa fever include Ondo 30 per cent Bauchi (25%), and Edo 17 per cent which together account for 72 per cent of all confirmed cases.

    The centre said that the disease was hitting young adults hardest, particularly those aged 21 to 30 years, with a nearly equal male-to-female ratio.

    It noted that no new healthcare worker infections were reported in the past week, but highlighted a surge in cases and called for heightened vigilance.

    The agency said that a multi-sectoral Incident Management System has been activated to coordinate response efforts nationwide.

    On the meningitis front, the centre said the figures were even more alarming.

    The NCDC said that from 2,911 suspected cases, 192 have been confirmed and 225 lives lost, translating to a case fatality rate of 7.7 per cent.

    The agency said that children aged five to 14 were the most affected, with males accounting for 60 per cent of all reported infections.

    It said that the outbreak has reached 24 states and 173 LGAs, with 10 northern states—including Kebbi, Katsina, Sokoto, and Jigawa—reporting 97 per cent of suspected cases.

    In response, the NCDC has activated a national Emergency Operations Centre to coordinate interventions in collaboration with the Federal Ministry of Health, the National Primary Health Care Development Agency (NPHCDA), the Nigerian Meteorological Agency (NiMet), and development partners.

    It said that regular high-level meetings with affected states were ongoing to streamline containment strategies.

    “We are providing continuous technical support to high-burden states and reinforcing outbreak preparedness across the country,” the NCDC said.

    Lassa fever is a viral hemorrhagic disease transmitted primarily through contact with the urine or faeces of infected rats.

    It can also spread from person to person through bodily fluids, contaminated objects, or infected medical equipment.

    Symptoms include fever, sore throat, headache, vomiting, muscle pain, and in severe cases, bleeding from body openings.

  • Infection spreads to 18 States as Lassa fever claims 138 lives

    Infection spreads to 18 States as Lassa fever claims 138 lives

    The Nigeria Centre for Disease Control and Prevention (NCDC), says Lassa fever has claimed 138 lives between January till date with a 19.3 per cent case fatality rate.

    This is according to the NCDC latest situation report shared via its official website. The report says the figure is a rise from the 18.0 per cent recorded within the same period in 2024.

    The reports also said that a total of 717 confirmed cases have been recorded as of Epi Week 18, with four new states (Ondo, Edo, Bauchi, and Benue) reporting cases in the current week alone.

    The public health agency said that while the number of new confirmed cases slightly decreased from 11 to 10 in the past week, the overall death toll remained alarming.

    The report noted that 71 per cent of all confirmed cases originated from three states Ondo, 30 per cent, Bauchi, 25 per cent and Taraba, 16 per cent signaling persistent hotspots in spite of nationwide interventions.

    It added that the most affected age group was 21–30 years, with the male gender appearing slightly more affected than the female with a male-to-female ratio of 1:0.8.

    The agency however said that no healthcare worker was infected in the current week, though 22 healthcare workers have been affected so far this year.

    The report disclosed that the NCDC had activated a multi-partner, multi-sectoral Incident Management System and deployed 10 Rapid Response Teams across affected states.

    It said that the agency had also intensified contact tracing, community sensitisation, and distributed essential commodities like PPES, Ribavirin, body bags, and disinfectants.

    This it said is in collaboration with international partners such as the WHO, MSF, CEPI, and Georgetown University.

    The country has conducted multiple webinars, capacity-building trainings, and surveillance activities to combat the outbreak.

    However, the public health agency described that challenges to the responses were hampered by late presentation of cases, poor health-seeking behaviour, and low awareness levels in high-burden areas.

    It also said that poor environmental sanitation contributed to disease spread.

    The agency continues to urge Nigerians to maintain hygiene, report symptoms early, and avoid contact with rodents and their secretions.

    ”The public is also encouraged to follow NCDC advisories and utilise the toll-free line 6232 for inquiries,” it said.

    Lassa fever is a viral hemorrhagic disease transmitted primarily through contact with the urine or faeces of infected rats.

    It can also spread from person to person through bodily fluids, contaminated objects, or infected medical equipment.

    Symptoms include fever, sore throat, headache, vomiting, muscle pain, and in severe cases, bleeding from body openings.

  • Ogun announces outbreak of Lassa fever, confirms one dead

    Ogun announces outbreak of Lassa fever, confirms one dead

    Ogun Government has announced the outbreak of Lassa fever in the state while confirming its first case.

    This was made known in a statement by the Commissioner of Health, Dr Tomi Coker on Wednesday in Abeokuta.

    According to Coker, the index case is a 25-year-old female National Youth Service Corp (NYSC) member who fell sick while in Ondo.

    She explained that the corps member was thereafter brought to a secondary health facility in Ijebu-North Local Government Area on March 18 and later died the same day.

    She described Lassa fever as a viral Haemorrhagic disease that causes high grade fever, headache, general body weakness and sore throat.

    ”Other symptoms may include muscle pain, cough, nausea, vomiting, diarrhoea, chest pain and unexplained bleeding from the ears, eyes, nose, mouth and other body openings,” she said.

    She implored residents to promptly report to the hospital if they noticed any of these symptoms just as she advised all health facilities to step up infection prevention and control measures.

    ”Any case of febrile illness that has not responded to 48 hours use of anti-malaria or antibiotics should be raised as an index of suspicion for Lassa fever.

    ”We implore all health facilities in Ogun, public and private, to step up infection prevention and control measures and encourage compliance by all health facility staff.

    ”Healthcare workers that suspects Lassa fever in a patient are advised to call their Local Government Disease Surveillance and Notification Officer (LGA DSNO) whose numbers are placed in our health facilities.

    ”They can also call the State Disease Surveillance and Notification Officer (0703-421-4893) or State Epidemiologist (0808-425-0881).

    ”The ministry of health in collaboration with the Rapid Response Team at Ijebu North East are keeping the situation under control with enhanced surveillance and community engagement and mobilisation for effective response,” she added.

    The commissioner reaffirmed the state government’s dedication to protecting the health of its citizens through continuous surveillance and prompt response to infectious diseases.

  • Lassa Fever: Death toll rises to 15 in Edo

    Lassa Fever: Death toll rises to 15 in Edo

    The Edo Government has confirmed 15 deaths from Lassa fever since the outbreak of the disease in the state in December 2024.

    The Director of Public Health, Edo State Ministry of Health, Dr Stephenson Ojeifo, disclosed this on Tuesday in Benin while responding to concerns on social media regarding the government’s efforts in tackling the outbreak.

    “As of today, Edo State has recorded over 1,000 suspected cases of Lassa fever. Out of these, 103 have tested positive

    “From the 103 confirmed cases, we have recorded 15 deaths, while others have been treated and discharged,” he said.

    Ojeifo asserted that Gov. Monday Okpebholo had strengthened surveillance and contact tracing efforts, ensuring that all necessary resources were available to contain the outbreak.

    He, however, attributed the high mortality rate to late referrals, noting that many patients arrive at the Irrua Specialist Teaching Hospital (ISTH) in critical condition.

    “The problem is that patients are only referred to ISTH when their condition has deteriorated.

    “We have been sensitising residents to seek medical attention if they experience persistent fever that does not resolve, so that samples can be tested and treatment can commence early if needed,” he said.

    The director urged healthcare providers to avoid delays in referring suspected cases to designated treatment centres.

    He warned that any hospital found treating Lassa fever patients without proper authorisation would face sanctions.

    In addition to the Lassa fever outbreak, Ojeifo disclosed that the state had recorded 11 suspected cases of Mpox, with five confirmed positives.

    He, however, said that no deaths were recorded, as all affected individuals received timely medical attention.